A jab that could revolutionise breast cancer treatment

A jab that could revolutionise breast cancer treatment

Until recently the lifesaving wonderdrug Herceptin could basically be given with a drip within a 30-minute procedure, these days a shot form continues to be granted a licence for usage in great britain.


Not only will it free up precious time for staff and patients, it might save the NHS %uFFFD20million if presented nationwide.

Breast cancer charities and doctors welcomed the new treatment option that may assist the 25 % from the 49,000 breast cancer patients who have the particularly aggressive HER2 way of the disease.

Dr Mark Verrill, consultant medical oncologist in the Freeman Hospital in Newcastle, said: "As along with the power for patients, subcutaneous Herceptin frees capacity on busy chemotherapy day units."